S
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Price:
13.71
INR
-2.49%
Market Cap:
₹12.9B
Balance Sheet
Balance Sheet Decomposition
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd
Balance Sheet Decomposition is not available for
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd
Balance Sheet
Syncom Formulations (India) Ltd
Syncom Formulations (India) Ltd
Currency: INR
| Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
642
|
4
|
85
|
675
|
0
|
|
| Cash |
614
|
1
|
80
|
45
|
0
|
|
| Cash Equivalents |
28
|
3
|
5
|
630
|
0
|
|
| Short-Term Investments |
142
|
473
|
660
|
678
|
927
|
|
| Total Receivables |
748
|
676
|
833
|
1 140
|
1 288
|
|
| Accounts Receivables |
748
|
676
|
756
|
1 034
|
1 077
|
|
| Other Receivables |
0
|
0
|
76
|
106
|
210
|
|
| Inventory |
226
|
195
|
234
|
247
|
458
|
|
| Other Current Assets |
141
|
50
|
5
|
5
|
20
|
|
| Total Current Assets |
1 898
|
1 398
|
1 817
|
2 748
|
2 700
|
|
| PP&E Net |
446
|
527
|
688
|
723
|
775
|
|
| PP&E Gross |
0
|
0
|
688
|
723
|
775
|
|
| Accumulated Depreciation |
0
|
0
|
580
|
626
|
674
|
|
| Intangible Assets |
1
|
1
|
2
|
1
|
0
|
|
| Note Receivable |
3
|
3
|
5
|
5
|
7
|
|
| Long-Term Investments |
560
|
1 131
|
1 249
|
567
|
643
|
|
| Other Long-Term Assets |
8
|
22
|
18
|
2
|
8
|
|
| Total Assets |
2 916
N/A
|
3 082
+6%
|
3 778
+23%
|
4 047
+7%
|
4 133
+2%
|
|
| Liabilities | ||||||
| Accounts Payable |
293
|
138
|
204
|
241
|
428
|
|
| Accrued Liabilities |
0
|
0
|
6
|
6
|
1
|
|
| Short-Term Debt |
621
|
578
|
832
|
725
|
46
|
|
| Other Current Liabilities |
53
|
67
|
89
|
89
|
118
|
|
| Total Current Liabilities |
967
|
783
|
1 132
|
1 062
|
593
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
44
|
46
|
44
|
50
|
63
|
|
| Other Liabilities |
29
|
32
|
42
|
53
|
55
|
|
| Total Liabilities |
1 041
N/A
|
860
-17%
|
1 218
+42%
|
1 165
-4%
|
711
-39%
|
|
| Equity | ||||||
| Common Stock |
790
|
862
|
940
|
940
|
844
|
|
| Retained Earnings |
1 086
|
1 360
|
1 394
|
1 698
|
2 238
|
|
| Additional Paid In Capital |
0
|
0
|
244
|
244
|
244
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
18
|
0
|
96
|
|
| Total Equity |
1 876
N/A
|
2 222
+18%
|
2 560
+15%
|
2 881
+13%
|
3 422
+19%
|
|
| Total Liabilities & Equity |
2 916
N/A
|
3 082
+6%
|
3 778
+23%
|
4 047
+7%
|
4 133
+2%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
790
|
862
|
940
|
940
|
940
|
|
Switch to:
Switch to:
See Also
Discover More
